Knowledge Distillery

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

Predictive factors of smell recovery in a clinical series of 288 COVID-19 patients with olfactory dysfunction

Authors describe mRNA1273-elicited binding and neutralizing antibodies in 33 healthy adults in an ongoing phase 1 trial, 180 days after the second…

Our highlighted selection of miscellaneous Covid-related studies from the scientific press for February 2022

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Guillain-Barré syndrome following ChAdOx1-S/nCoV-19 vaccine

Whether or not people who have been infected SARS-CoV-2 should be vaccinated is unclear. This observational cohort study, the authors enrolled 100…

Our highlighted selection of Covid-related expert opinions from the scientific press for February 2022

Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19

Guillain-Barré syndrome variant occurring after SARS-CoV-2 vaccination

In this article, the authors report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving…

Our highlighted selection of Covid-related interventional studies with open label or non-randomised methodology from the scientific press for February…